Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives

Lung cancer is the most common cancer in the world. Despite modern advancements in surgeries, chemotherapies, and radiotherapies over the past few years, lung cancer still remains a very difficult disease to treat. This has left the death rate from lung cancer victims largely unchanged throughout th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Joy, Salama, Rasha, Gadgeel, Shirish M., Sarkar, Fazlul H., Ahmad, Aamir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570789/
https://www.ncbi.nlm.nih.gov/pubmed/23407898
http://dx.doi.org/10.3389/fphar.2013.00015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570789/
https://www.ncbi.nlm.nih.gov/pubmed/23407898
http://dx.doi.org/10.3389/fphar.2013.00015

Ejemplares similares